{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T23:06:58Z","timestamp":1773702418054,"version":"3.50.1"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI158177"],"award-info":[{"award-number":["AI158177"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.mam.2021.101008","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T03:45:34Z","timestamp":1628826334000},"page":"101008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Innate lymphoid cells (ILC) in SARS-CoV-2 infection"],"prefix":"10.1016","volume":"80","author":[{"given":"Amrita","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kedan","family":"Endrias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8640-254X","authenticated-orcid":false,"given":"Suresh V.","family":"Kuchipudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh K.","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4715-5793","authenticated-orcid":false,"given":"Suryaprakash","family":"Sambhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mam.2021.101008_bib1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3389\/fimmu.2017.00699","article-title":"Human CD56(dim)CD16(dim) cells as an individualized natural killer cell subset","volume":"8","author":"Amand","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2021.101008_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fimmu.2019.00092","article-title":"Type 3 ILCs in lung disease","volume":"10","author":"Ardain","year":"2019","journal-title":"Front. Immunol."},{"issue":"6536","key":"10.1016\/j.mam.2021.101008_bib3","first-page":"371","article-title":"Liver type 1 innate lymphoid cells develop locally via an interferon-gamma-dependent loop","author":"Bai","year":"2021","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.mam.2021.101008_bib4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijrobp.2017.04.014","article-title":"Stimulating innate immunity to enhance radiation therapy-induced tumor control","volume":"99","author":"Baird","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"9","key":"10.1016\/j.mam.2021.101008_bib5","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41577-020-0282-9","article-title":"Plasticity of innate lymphoid cell subsets","volume":"20","author":"Bal","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mam.2021.101008_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-physiol-020518-114630","article-title":"Innate lymphoid cells of the lung","volume":"81","author":"Barlow","year":"2019","journal-title":"Annu. Rev. Physiol."},{"issue":"6","key":"10.1016\/j.mam.2021.101008_bib7","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.immuni.2020.11.017","article-title":"Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19","volume":"53","author":"Bernardes","year":"2020","journal-title":"Immunity"},{"issue":"26","key":"10.1016\/j.mam.2021.101008_bib8","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJM198906293202605","article-title":"Severe herpesvirus infections in an adolescent without natural killer cells","volume":"320","author":"Biron","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2021.101008_bib9","series-title":"COVID Data Tracker","author":"Centers for Disease Control","year":"2021"},{"key":"10.1016\/j.mam.2021.101008_bib10","doi-asserted-by":"crossref","first-page":"m3862","DOI":"10.1136\/bmj.m3862","article-title":"Virology, transmission, and pathogenesis of SARS-CoV-2","volume":"371","author":"Cevik","year":"2020","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.mam.2021.101008_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41577-020-0402-6","article-title":"T cell responses in patients with COVID-19","volume":"20","author":"Chen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.mam.2021.101008_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001347","article-title":"Programmed death (PD)-1-deficient mice are extremely sensitive to murine hepatitis virus strain-3 (MHV-3) infection","volume":"7","author":"Chen","year":"2011","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.mam.2021.101008_bib13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.coi.2012.02.003","article-title":"The development of LTi cells","volume":"24","author":"Cherrier","year":"2012","journal-title":"Curr. Opin. Immunol."},{"issue":"7496","key":"10.1016\/j.mam.2021.101008_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nature13047","article-title":"A committed precursor to innate lymphoid cells","volume":"508","author":"Constantinides","year":"2014","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.mam.2021.101008_bib15","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1073\/pnas.0813192106","article-title":"Cytokine-induced memory-like natural killer cells","volume":"106","author":"Cooper","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mam.2021.101008_bib16","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3389\/fimmu.2018.01671","article-title":"Human CD49a(+) lung natural killer cell cytotoxicity in response to influenza A virus","volume":"9","author":"Cooper","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.mam.2021.101008_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm.4278","article-title":"A distinct innate lymphoid cell population regulates tumor-associated T cells","volume":"23","author":"Crome","year":"2017","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.mam.2021.101008_bib18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.immuni.2019.02.002","article-title":"Adventitial stromal cells define group 2 innate lymphoid cell tissue niches","volume":"50","author":"Dahlgren","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.mam.2021.101008_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.it.2020.11.002","article-title":"T cells: warriors of SARS-CoV-2 infection","volume":"42","author":"de Candia","year":"2021","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.mam.2021.101008_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145961","article-title":"Characterization and quantification of innate lymphoid cell subsets in human lung","volume":"11","author":"De Grove","year":"2016","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.mam.2021.101008_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/cyto.b.21508","article-title":"Markers and function of human NK cells in normal and pathological conditions","volume":"92","author":"Del Zotto","year":"2017","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.mam.2021.101008_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3389\/fimmu.2016.00351","article-title":"Features of memory-like and PD-1(+) human NK cell subsets","volume":"7","author":"Della Chiesa","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2021.101008_bib23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.mam.2021.101008_bib24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cell.2020.01.022","article-title":"Tissue determinants of human NK cell development, function, and residence","volume":"180","author":"Dogra","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.mam.2021.101008_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.mam.2021.101008_bib26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ni1022","article-title":"An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells","volume":"5","author":"Eberl","year":"2004","journal-title":"Nat. Immunol."},{"issue":"6237","key":"10.1016\/j.mam.2021.101008_bib27","doi-asserted-by":"crossref","first-page":"aaa6566","DOI":"10.1126\/science.aaa6566","article-title":"Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology","volume":"348","author":"Eberl","year":"2015","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.mam.2021.101008_bib28","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMicm2023328","article-title":"SARS-CoV-2 infection of airway cells","volume":"383","author":"Ehre","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.mam.2021.101008_bib29","article-title":"Guidelines of care for the management of actinic keratosis","volume":"S0190-9622","author":"Eisen","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"issue":"11","key":"10.1016\/j.mam.2021.101008_bib30","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1182\/blood-2009-08-238469","article-title":"Regulation of human NK-cell cytokine and chemokine production by target cell recognition","volume":"115","author":"Fauriat","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.mam.2021.101008_bib31","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.6556","article-title":"Mortality among US patients hospitalized with SARS-CoV-2 infection in 2020","volume":"4","author":"Finelli","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.mam.2021.101008_bib32","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","article-title":"Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells","volume":"38","author":"Fuchs","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.mam.2021.101008_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1376595","article-title":"The memories of NK cells: innate-adaptive immune intrinsic crosstalk","volume":"2016","author":"Gabrielli","year":"2016","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.mam.2021.101008_bib34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","article-title":"Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison","volume":"22","author":"Galani","year":"2021","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.mam.2021.101008_bib35","doi-asserted-by":"crossref","first-page":"e1224","DOI":"10.1002\/cti2.1224","article-title":"Innate lymphoid cell composition associates with COVID-19 disease severity","volume":"9","author":"Garcia","year":"2020","journal-title":"Clin Transl Immunology"},{"issue":"6263","key":"10.1016\/j.mam.2021.101008_bib36","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1126\/science.aac9593","article-title":"Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs","volume":"350","author":"Gasteiger","year":"2015","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.mam.2021.101008_bib37","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 Days in patients with severe covid-19","volume":"383","author":"Goldman","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.mam.2021.101008_bib38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41423-020-00596-2","article-title":"Severe COVID-19 patients exhibit an ILC2 NKG2D(+) population in their impaired ILC compartment","volume":"18","author":"Gomez-Cadena","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"13","key":"10.1016\/j.mam.2021.101008_bib39","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1182\/blood-2010-04-281394","article-title":"Natural killer-cell differentiation by myeloid progenitors","volume":"117","author":"Grzywacz","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mam.2021.101008_bib40","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.immuni.2014.01.011","article-title":"Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation","volume":"40","author":"Halim","year":"2014","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.mam.2021.101008_bib41","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s41590-018-0163-6","article-title":"Natural killer cell specificity for viral infections","volume":"19","author":"Hammer","year":"2018","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.mam.2021.101008_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092276","article-title":"Group 2 innate lymphoid cells (ILC2): type 2 immunity and helminth immunity","volume":"20","author":"Herbert","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.mam.2021.101008_bib43","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/eji.201848006","article-title":"Expression of c-Kit discriminates between two functionally distinct subsets of human type 2 innate lymphoid cells","volume":"49","author":"Hochdorfer","year":"2019","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.mam.2021.101008_bib44","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1128\/JVI.01675-09","article-title":"HIV infection is associated with a preferential decline in less-differentiated CD56dim CD16+ NK cells","volume":"84","author":"Hong","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.mam.2021.101008_bib45","first-page":"88","article-title":"Activation of natural killer cells during microbial infections","volume":"2","author":"Horowitz","year":"2011","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.mam.2021.101008_bib46","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.immuni.2012.06.020","article-title":"The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells","volume":"37","author":"Hoyler","year":"2012","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.mam.2021.101008_bib47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00042560-199511000-00005","article-title":"Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity","volume":"10","author":"Hu","year":"1995","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.mam.2021.101008_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2021.107876","article-title":"Screening of small molecule libraries using combined text mining, ligand- and target-driven based approaches for identification of novel granzyme H inhibitors","volume":"105","author":"Ikram","year":"2021","journal-title":"J. Mol. Graph. Model."},{"issue":"1","key":"10.1016\/j.mam.2021.101008_bib49","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1080\/21505594.2021.1898790","article-title":"Immune dysregulation and system pathology in COVID-19","volume":"12","author":"Jamal","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/j.mam.2021.101008_bib50","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3389\/fcimb.2020.00364","article-title":"Immune parameters and COVID-19 infection - associations with clinical severity and disease prognosis","volume":"10","author":"Jesenak","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10.1016\/j.mam.2021.101008_bib51","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1084\/jem.143.4.772","article-title":"Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems","volume":"143","author":"Kiessling","year":"1976","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.mam.2021.101008_bib52","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ni.3489","article-title":"Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis","volume":"17","author":"Klose","year":"2016","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.mam.2021.101008_bib53","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41422-020-0323-8","article-title":"Innate lymphoid cells control signaling circuits to regulate tissue-specific immunity","volume":"30","author":"Klose","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.mam.2021.101008_bib54","first-page":"215","article-title":"Transcription factors controlling innate lymphoid cell fate decisions","volume":"381","author":"Klose","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"2","key":"10.1016\/j.mam.2021.101008_bib55","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cell.2014.03.030","article-title":"Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages","volume":"157","author":"Klose","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.mam.2021.101008_bib56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coi.2020.08.007","article-title":"Innate lymphoid cells: from helper to killer","volume":"68","author":"Krabbendam","year":"2021","journal-title":"Curr. Opin. Immunol."},{"issue":"49","key":"10.1016\/j.mam.2021.101008_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd7114","article-title":"Comprehensive mapping of immune perturbations associated with severe COVID-19","volume":"5","author":"Kuri-Cervantes","year":"2020","journal-title":"Sci Immunol"},{"issue":"6","key":"10.1016\/j.mam.2021.101008_bib58","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.jaci.2019.01.047","article-title":"Gene expression signatures of circulating human type 1, 2, and 3 innate lymphoid cells","volume":"143","author":"Li","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.mam.2021.101008_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.580237","article-title":"Elevated exhaustion levels of NK and CD8(+) T cells as indicators for progression and prognosis of COVID-19 disease","volume":"11","author":"Li","year":"2020","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.mam.2021.101008_bib60","first-page":"2064","article-title":"Role of NKG2D and its ligands in cancer immunotherapy","volume":"9","author":"Liu","year":"2019","journal-title":"Am J Cancer Res"},{"issue":"4","key":"10.1016\/j.mam.2021.101008_bib61","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jaci.2016.07.043","article-title":"Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69(-)CD56(dim) cells","volume":"139","author":"Marquardt","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6508","key":"10.1016\/j.mam.2021.101008_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","volume":"369","author":"Mathew","year":"2020","journal-title":"Science"},{"issue":"50","key":"10.1016\/j.mam.2021.101008_bib63","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd6832","article-title":"Natural killer cell immunotypes related to COVID-19 disease severity","volume":"5","author":"Maucourant","year":"2020","journal-title":"Sci Immunol"},{"issue":"9","key":"10.1016\/j.mam.2021.101008_bib64","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1172\/JCI138554","article-title":"Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent","volume":"130","author":"Mazzoni","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.mam.2021.101008_bib65","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41422-020-00445-x","article-title":"Tissue-specific transcriptional imprinting and heterogeneity in human innate lymphoid cells revealed by full-length single-cell RNA-sequencing","volume":"31","author":"Mazzurana","year":"2021","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.mam.2021.101008_bib66","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2012.08.015","article-title":"The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells","volume":"37","author":"Mjosberg","year":"2012","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.mam.2021.101008_bib67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.immuni.2015.05.019","article-title":"Interleukin-33 and interferon-gamma counter-regulate group 2 innate lymphoid cell activation during immune perturbation","volume":"43","author":"Molofsky","year":"2015","journal-title":"Immunity"},{"issue":"7280","key":"10.1016\/j.mam.2021.101008_bib68","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature08636","article-title":"Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells","volume":"463","author":"Moro","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.mam.2021.101008_bib69","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fimmu.2018.00191","article-title":"Cytokine networks between innate lymphoid cells and myeloid cells","volume":"9","author":"Mortha","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.mam.2021.101008_bib70","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.immuni.2021.01.002","article-title":"ILC1: guardians of the oral mucosa against enemy viruses","volume":"54","author":"Nabekura","year":"2021","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.mam.2021.101008_bib71","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bj.2020.10.001","article-title":"Type 1 innate lymphoid cells: soldiers at the front line of immunity","volume":"44","author":"Nabekura","year":"2021","journal-title":"Biomed. J."},{"issue":"4","key":"10.1016\/j.mam.2021.101008_bib72","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/vim.2011.0096","article-title":"PD-1 expression on natural killer cells and CD8(+) T cells during chronic HIV-1 infection","volume":"25","author":"Norris","year":"2012","journal-title":"Viral Immunol."},{"issue":"7470","key":"10.1016\/j.mam.2021.101008_bib73","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nature12526","article-title":"Type 2 innate lymphoid cells control eosinophil homeostasis","volume":"502","author":"Nussbaum","year":"2013","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.mam.2021.101008_bib74","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1080\/21645515.2020.1802974","article-title":"Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses","volume":"16","author":"O'Connell","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"issue":"1","key":"10.1016\/j.mam.2021.101008_bib75","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s42003-021-02079-0","article-title":"A follicular regulatory Innate Lymphoid Cell population impairs interactions between germinal center Tfh and B cells","volume":"4","author":"O'Connor","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.mam.2021.101008_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2021.03.002","article-title":"COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?","volume":"232","author":"Ombrello","year":"2021","journal-title":"Transl. Res."},{"issue":"15","key":"10.1016\/j.mam.2021.101008_bib77","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S1286-4579(02)00038-2","article-title":"Human natural killer cell deficiencies and susceptibility to infection","volume":"4","author":"Orange","year":"2002","journal-title":"Microb. Infect."},{"issue":"1","key":"10.1016\/j.mam.2021.101008_bib78","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nri.2017.76","article-title":"Single-cell RNA sequencing to explore immune cell heterogeneity","volume":"18","author":"Papalexi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mam.2021.101008_bib79","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3389\/fimmu.2019.01179","article-title":"Killer ig-like receptors (KIRs): their role in NK cell modulation and developments leading to their clinical exploitation","volume":"10","author":"Pende","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2021.101008_bib80","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3389\/fimmu.2019.01179","article-title":"Killer ig-like receptors (KIRs): their role in NK cell modulation and developments leading to their clinical exploitation","volume":"10","author":"Pende","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.mam.2021.101008_bib81","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2016.04.025","article-title":"Identification of a subset of human natural killer cells expressing high levels of programmed death 1: a phenotypic and functional characterization","volume":"139","author":"Pesce","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.mam.2021.101008_bib82","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.mam.2021.101008_bib83","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/10408363.2020.1770685","article-title":"Biomarkers associated with COVID-19 disease progression","volume":"57","author":"Ponti","year":"2020","journal-title":"Crit. Rev. Clin. Lab Sci."},{"issue":"25","key":"10.1016\/j.mam.2021.101008_bib84","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1073\/pnas.1003988107","article-title":"Systemically dispersed innate IL-13-expressing cells in type 2 immunity","volume":"107","author":"Price","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.mam.2021.101008_bib85","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41590-018-0185-0","article-title":"Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells","volume":"19","author":"Quatrini","year":"2018","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.mam.2021.101008_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113285","article-title":"The immune checkpoint PD-1 in natural killer cells: expression, function and targeting in tumour immunotherapy","volume":"12","author":"Quatrini","year":"2020","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.mam.2021.101008_bib87","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5045\/kjh.2011.46.4.216","article-title":"Human diversity of killer cell immunoglobulin-like receptors and disease","volume":"46","author":"Rajalingam","year":"2011","journal-title":"Korean J Hematol"},{"issue":"8","key":"10.1016\/j.mam.2021.101008_bib88","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molmed.2009.06.003","article-title":"Cytoplasmic nucleic acid sensors in antiviral immunity","volume":"15","author":"Ranjan","year":"2009","journal-title":"Trends Mol. Med."},{"issue":"8","key":"10.1016\/j.mam.2021.101008_bib89","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.celrep.2017.01.071","article-title":"First-breath-induced type 2 pathways shape the lung immune environment","volume":"18","author":"Saluzzo","year":"2017","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.mam.2021.101008_bib90","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ni.1605","article-title":"Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone","volume":"9","author":"Scandella","year":"2008","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.mam.2021.101008_bib91","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.mam.2021.101008_bib92","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.3389\/fimmu.2019.02897","article-title":"Interleukin-7 receptor alpha in innate lymphoid cells: more than a marker","volume":"10","author":"Sheikh","year":"2019","journal-title":"Front. Immunol."},{"issue":"7835","key":"10.1016\/j.mam.2021.101008_bib93","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","article-title":"Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity","volume":"587","author":"Shin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.mam.2021.101008_bib94","article-title":"Innate lymphoid cells and disease tolerance in SARS-CoV-2 infection","author":"Silverstein","year":"2021","journal-title":"medRxiv"},{"issue":"3","key":"10.1016\/j.mam.2021.101008_bib95","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/imm.12862","article-title":"Dissecting human ILC heterogeneity: more than just three subsets","volume":"153","author":"Simoni","year":"2018","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.mam.2021.101008_bib96","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.immuni.2016.11.005","article-title":"Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency","volume":"46","author":"Simoni","year":"2017","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.mam.2021.101008_bib97","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41577-019-0194-8","article-title":"Functional interactions between innate lymphoid cells and adaptive immunity","volume":"19","author":"Sonnenberg","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.mam.2021.101008_bib98","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/imr.12712","article-title":"Innate lymphoid cells in lung infection and immunity","volume":"286","author":"Stehle","year":"2018","journal-title":"Immunol. Rev."},{"issue":"7","key":"10.1016\/j.mam.2021.101008_bib99","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.mam.2021.101008_bib100","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.4049\/jimmunol.178.12.7540","article-title":"Type I IFN contributes to NK cell homeostasis, activation, and antitumor function","volume":"178","author":"Swann","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.mam.2021.101008_bib101","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/s41598-019-38864-5","article-title":"Intranasal and epicutaneous administration of Toll-like receptor 7 (TLR7) agonists provides protection against influenza A virus-induced morbidity in mice","volume":"9","author":"To","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.mam.2021.101008_bib102","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/mi.2014.63","article-title":"Identification of diverse innate lymphoid cells in human decidua","volume":"8","author":"Vacca","year":"2015","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.mam.2021.101008_bib103","unstructured":"van de Pavert SA. Lymphoid tissue inducer (LTi) cell ontogeny and functioning in embryo and adult,."},{"issue":"1","key":"10.1016\/j.mam.2021.101008_bib104","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000496212","article-title":"Group 2 innate lymphoid cells in human respiratory disorders","volume":"12","author":"van der Ploeg","year":"2020","journal-title":"J Innate Immun"},{"issue":"3","key":"10.1016\/j.mam.2021.101008_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/v11030243","article-title":"Viral infection of human natural killer cells","volume":"11","author":"van Erp","year":"2019","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.mam.2021.101008_bib106","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41423-020-00557-9","article-title":"Unique immunological profile in patients with COVID-19","volume":"18","author":"Varchetta","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"57","key":"10.1016\/j.mam.2021.101008_bib107","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf7570","article-title":"Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19","volume":"6","author":"Vella","year":"2021","journal-title":"Sci Immunol"},{"issue":"7","key":"10.1016\/j.mam.2021.101008_bib108","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood-2005-03-1154","article-title":"Natural-killer cells and dendritic cells: \"l'union fait la force","volume":"106","author":"Walzer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.mam.2021.101008_bib109","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fimmu.2015.00368","article-title":"NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy","volume":"6","author":"Wang","year":"2015","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.mam.2021.101008_bib110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cell.2017.07.027","article-title":"Regulatory innate lymphoid cells control innate intestinal inflammation","volume":"171","author":"Wang","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.mam.2021.101008_bib111","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13063-020-04352-9","article-title":"Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial","volume":"21","author":"Wang","year":"2020","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.mam.2021.101008_bib112","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41422-020-00460-y","article-title":"AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells","volume":"31","author":"Wang","year":"2021","journal-title":"Cell Res."},{"issue":"8","key":"10.1016\/j.mam.2021.101008_bib113","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"J. Am. Med. Assoc."},{"issue":"4","key":"10.1016\/j.mam.2021.101008_bib114","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"24","key":"10.1016\/j.mam.2021.101008_bib115","doi-asserted-by":"crossref","first-page":"14270","DOI":"10.1111\/jcmm.16044","article-title":"Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19","volume":"24","author":"Yan","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.mam.2021.101008_bib116","doi-asserted-by":"crossref","first-page":"108590","DOI":"10.1016\/j.celrep.2020.108590","article-title":"Cell-type-specific immune dysregulation in severely ill COVID-19 patients","volume":"34","author":"Yao","year":"2021","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.mam.2021.101008_bib117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150606","article-title":"A protocol for the comprehensive flow cytometric analysis of immune cells in normal and inflamed murine non-lymphoid tissues","volume":"11","author":"Yu","year":"2016","journal-title":"PloS One"},{"issue":"56","key":"10.1016\/j.mam.2021.101008_bib118","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf6692","article-title":"Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients","volume":"6","author":"Zhao","year":"2021","journal-title":"Sci Immunol"},{"issue":"5","key":"10.1016\/j.mam.2021.101008_bib119","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"10","key":"10.1016\/j.mam.2021.101008_bib120","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s13238-020-00762-2","article-title":"A human circulating immune cell landscape in aging and COVID-19","volume":"11","author":"Zheng","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.mam.2021.101008_bib121","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cytogfr.2018.02.004","article-title":"Lymphoid tissue inducer-A divergent member of the ILC family","volume":"42","author":"Zhong","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"issue":"3","key":"10.1016\/j.mam.2021.101008_bib122","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.immuni.2020.07.009","article-title":"Single-cell sequencing of peripheral mononuclear cells reveals distinct immune response landscapes of COVID-19 and influenza patients","volume":"53","author":"Zhu","year":"2020","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.mam.2021.101008_bib123","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.molcel.2017.01.023","article-title":"Comparative analysis of single-cell RNA sequencing methods","volume":"65","author":"Ziegenhain","year":"2017","journal-title":"Mol. Cell."},{"issue":"9","key":"10.1016\/j.mam.2021.101008_bib124","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1096\/fasebj.6.9.1612293","article-title":"The renewal and differentiation of hemopoietic stem cells","volume":"6","author":"Zipori","year":"1992","journal-title":"Faseb. J."},{"key":"10.1016\/j.mam.2021.101008_bib125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cytogfr.2018.08.001","article-title":"Natural killer cells in inflammation and autoimmunity","volume":"42","author":"Zitti","year":"2018","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299721000686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299721000686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:16:19Z","timestamp":1758824179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299721000686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":125,"alternative-id":["S0098299721000686"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2021.101008","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innate lymphoid cells (ILC) in SARS-CoV-2 infection","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2021.101008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101008"}}